Vivimed Labs Share price

History & Background of the CompanyThe Company was originally promoted by Mr. A. M. Rao and incorporatedas Emgi Pharmaceuticals & Chemicals Private Limited on September 221988 with Registrar of Companies of Karnataka Bangalore. On Mr. Rao'saccidental death the Company was put for a sale. In 1989 Mr. SantoshVaralwar and Mr. Subhash Varalwar acquired Emgi Pharmaceuticals andChemicals Limited and commenced manufacturing of Bulk Drugs in 1991.Both the present promoters are professionals with more than a decade ofexperience in Chemicals and Pharmaceutical Industry. The Company wasconverted into a Public Limited Company on April 4 1994. The name ofthe Company has been changed to Vivimed Labs Limited on April 22 1997.The name of the Company has been changed to incorporate presentPromoter's initials in the Company's name.The Company's manufacturing Unit is located at Bidar Karnataka whereit was originally engaged in the manufacturing of Active PharmaceuticalIngredients (APIs) and Bulk Drugs like Ibuprofen etc. However due todownward price movement in the products of the Company during 1995 itgradually moved over to manufacturing Specialty Chemicals and cosmeticingredients like Triclosan Avis etc. catering to global and domesticmarkets.Vivimed started production of Triclosan with a very small capacity of 5MT p.a in the year 1999 and increased its capacity to 225 MT p.a. overa period of next 5 years. The production capacity has been doubled byadding one more production block in March 2004. The Company currentlyemploys over 250 personnel including contract laborers.Vivimed's Turnover has grown from Rs. 751.85 lacs in FY1999 to Rs.4042.55 lacs in FY2004 and its Net profit grew from Rs. 15.26 lacs inFY1999 to Rs. 400.28 lacs in FY2004. The Turnover of the Company for 6months period ended September 30 2004 is Rs. 2322.60 Lacs and NetProfit is Rs.249.24 lacs. As at September 30 2004 the Networth of theCompany was Rs. 1850.15 lacs.The Company has ISO 9001:2000 certification for its Quality ManagementSystem related to manufacturing process and marketing aspects. Furtherthe Company is in the process of obtaining ISO 14001 certification forEnvironmental Management System for which two Audits have already beencompleted.Major events In -the history of the Company is given below:Year Event1988 & * Incorporated on September 22 19881989 * Death of original promoter Mr. A. M. Rao * Acquired by Mr. Santosh Varalwar and Mr. Subhash Varalwar1990 * Commenced production of Non-Steroidal Anti-Inflammatory Drug (NSAID) - IBUPROFEN.1994 * Diversification and Expansion of Product mix by adding other APIs viz. Chlorzoxazone (Skeletal disorders) Nalidixic Acid (Anti-diarrheas) and Flucanazole (Anti-fungal).1995 * Diversification into specialty chemicals by production of Triclosan.1996 * R&D was commenced with facilities having an integrated instrumentation for organic synthesis Microbiology and pre-formulation studies.1997 * Process Innovation of Anti-bacterial and clearance of innovative route of synthesis for Triclosan. * Grant of patent for VIV-20 (Triclosan) by the Indian Patents Office.1998- * Qualified for supply to Unilever's Asian locations after 99 Audit of manufacturing facility by a team of Unilever Plc. * Triclosan customer base expanded to UK France Germany as well as domestic market;2002 * Approved by Unilever group Companies in Asian/Middle & Far East Companies for usage of Enamel Protective Agent manufactured by the Company in their oral care formulations. * Developed Anti-fungal for usage in High-end cosmetic and pre-formulation blends. * Vivimed emerges as a second chemical Company located outside USA/Europe to get the US EPA's registration for Triclosan as 99% ingredient. * Vivimed's Quality Management System gets ISO 9001:2000 certification.2003 * Signed Confidential Sale Agreement with HLL for R&D scaling up and commercialization of product coded as A123. * Commencement of EMS Audit for ISO 14001 certification.2004 * Introduced new products for anti-dandruff and skin care application * Triclosan production capacity increased from 225 MT p.a. to 480 MT p.a. * Developed novel synthetic process to manufacture a premium Anti-oxidant and Anti-cancer molecule branded as VINTOX2005 * The Company has received the State Award for Excellence in Exports (SSI GOLD) from Karnataka State Government for excellence in exports * The Company has received 1 star export house status in 2005.